The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Open accessAbstract
Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of viral hepatitis, insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH), disorders that increase risk of hepatocellular carcinoma (HCC). To determine whether and how ER stress contributes to obesity-driven hepatic tumorigenesis we fed wild-type (WT) and MUP-uPA mice, in which hepatocyte ER stress is induced by plasminogen activator expression, with high-fat diet. Although both strains were equally insulin resistant, the MUP-uPA mice exhibited more liver damage, more immune infiltration, and increased lipogenesis and, as a result, displayed classical NASH signs and developed typical steatohepatitic HCC. Both NASH and HCC development were dependent on TNF produced by inflammatory macrophages that accumulate in the MUP-uPA liver in response to hepatocyte ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several transgenic animals have been developed to study MASH pathogenesis, including those that overexpress urokinase-type plasminogen activator (MUP-uPA) (221) or sterol regulatory element-binding protein 1 (SREBP1) (222, 223).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Self-citationProtein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Cited by
Sorted by citations
Items 201–300 of 526
Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC
Boslem, E., Reibe, S., Carlessi, R., Smeuninx, B., Tegegne, S., Egan, C. L., McLennan, E., Terry, L. V., Nobis, M., Mu, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh0831 · Cited by 39
Self-citationUnfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review
Shreya, S., Grosset, C. F., & Jain, B. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814066 · Cited by 42
Passos, E., Ascensão, A. A. M. R., Martins, M. J., & Magalhães, J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.02.003 · Cited by 40
Aslam, M. N., Bassis, C. M., Zhang, L. R., Zaidi, S. A. A., Varani, J., & Bergin, I. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166178 · Cited by 39
Zhou, Y., Wu, C., Wang, X., Li, P., Fan, N., Zhang, W., Liu, Z., Zhang, W., & Tang, B. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01776 · Cited by 39
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
Richter, F., Williams, S. K., John, K., Huber, C., Vaslin, C., Zanker, H. S., Fairless, R., Pichi, K., Marhenke, S., Vogel, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705485 · Cited by 39
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Karin, M., & Kim, J. Y. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13685 · Cited by 45
Self-citationMaurel, M., Samali, A., & Chevet, É. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.08.007 · Cited by 39
Sánchez‐Álvarez, M., Zhang, Q., Finger, F., Wakelam, M. J. O., & Bakal, C. (2015) · Open Biology · doi:10.1098/rsob.150093 · Cited by 38
Takakura, K., Oikawa, T., Nakano, M., Saeki, C., Torisu, Y., Kajihara, M., & Saruta, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00762 · Cited by 40
Delgadillo-Puga, C., Noriega, L. G., Morales-Romero, A. M., Nieto‐Camacho, A., Granados‐Portillo, O., Rodríguez-López, L. A., Alemán, G., Furuzawa‐Carballeda, J., Tovar, A. R., Cisneros‐Zevallos, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155530 · Cited by 38
Green, C. D., Weigel, C., Brown, R. D. R., Bédossa, P., Dozmorov, M. G., Sanyal, A. J., & Spiegel, S. (2022) · The FASEB Journal · doi:10.1096/fj.202200346r · Cited by 38
Aghayev, T., Mazitova, A., Fang, J. R., Peshkova, I. O., Rausch, M. P., Hung, M., White, K., Masia, R., Titerina, E. K., Fatkhullina, A. R., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1628 · Cited by 38
Lebeaupin, C., Yong, J., & Kaufman, R. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_8 · Cited by 38
Self-citationCarlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
Galun, D. A., Mijac, D. D., Filipović, A., Bogdanović, A., Zivanovic, M., & Mašulović, D. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020149 · Cited by 39
Kapelanski‐Lamoureux, A., Chen, Z., Gao, Z., Deng, R., Lazaris, A., Lebeaupin, C., Giles, L., Malhotra, J. D., Yong, J., Zou, C., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.004 · Cited by 38
Self-citationShao, G., Liu, Y., Lu, L., Zhang, G., Zhou, W., Wu, T., Wang, L., Xu, H., & Ji, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944088 · Cited by 37
Kim, J. Y., Wang, L. Q., Sladky, V. C., Oh, T. G., Liu, J., Trinh, K., Eichin, F., Downes, M., Hosseini, M., Jacotot, E. D., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.005 · Cited by 37
Self-citationGalun, E. (2015) · Hepatology · doi:10.1002/hep.28344 · Cited by 36
Conceptual models for the initiation of hepatitis B virus‐associated hepatocellular carcinoma
Tu, T., Budzinska, M. A., Shackel, N. A., & Jilbert, A. R. (2014) · Liver International · doi:10.1111/liv.12773 · Cited by 35
Kakehashi, A., Suzuki, S., Ishii, N., Okuno, T., Kuwae, Y., Fujioka, M., Gi, M., Стефанов, В. Е., & Wanibuchi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207746 · Cited by 37
Tan, N., Liu, Q., Liu, X., Gong, Z., Zeng, Y., Pan, G., Xu, Q. R., & He, S. (2015) · Histopathology · doi:10.1111/his.12738 · Cited by 34
Lahlali, T., Plissonnier, M., Romero‐López, C., Michelet, M., Ducarouge, B., Berzal‐Herranz, A., Zoulim, F., Mehlen, P., & Parent, R. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.12.011 · Cited by 36
Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis
Van, T.-M., Polykratis, A., Straub, B. K., Kondylis, V., Papadopoulou, N., & Pasparakis, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92508 · Cited by 35
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
Kurosaki, S., Nakagawa, H., Hayata, Y., Kawamura, S., Matsushita, Y., Yamada, T., Uchino, K., Hayakawa, Y., Suzuki, N., Hata, M., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100315 · Cited by 34
Self-citationHistone Modifications in NAFLD: Mechanisms and Potential Therapy
Shi, Y., & Qi, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914653 · Cited by 34
Harris, S., Poolman, T. M., Arvaniti, A., Cox, R., Gathercole, L., & Tomlinson, J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2020 · Cited by 35
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice
Weber, A. A., Yang, X., Mennillo, E., Ding, J., Watrous, J. D., Jain, M., Chen, S., Karin, M., & Tukey, R. H. (2022) · Nature Communications · doi:10.1038/s41467-022-31947-4 · Cited by 30
Self-citationKurusu, R., Fujimoto, Y., Morishita, H., Noshiro, D., Takada, S., Yamano, K., Tanaka, H., Arai, R., Kageyama, S., Funakoshi, T., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.04.015 · Cited by 32
From Liver Fat to Cancer: Perils of the Western Diet
Kim, J. Y., He, F., & Karin, M. (2021) · Cancers · doi:10.3390/cancers13051095 · Cited by 32
Self-citationα-Lipoic acid induces Endoplasmic Reticulum stress-mediated apoptosis in hepatoma cells
Pibiri, M., Sulas, P., Camboni, T., Leoni, V. P., & Simbula, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-64004-5 · Cited by 31
The adiponectin-PPARγ axis in hepatic stellate cells regulates liver fibrosis
Zhao, S., Zhu, Q., Lee, W., Funcke, J., Zhang, Z., Wang, M.-Y., Lin, Q., Field, B. C., Sun, X.-N., Li, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115165 · Cited by 32
Tan, Y., Zhang, X., Zhang, W., Tang, L., Yang, H., Yan, K., Jiang, L., Yang, J., Li, C., Yang, J., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0303 · Cited by 30
Zou, Y., & Qi, Z. (2020) · Mediators of Inflammation · doi:10.1155/2020/6412916 · Cited by 29
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
Datfar, T., Doulberis, M., Papaefthymiou, A., Hines, I. N., & Manzini, G. (2021) · Pathogens · doi:10.3390/pathogens10111366 · Cited by 31
Nakatsuka, T., Tateishi, K., Kato, H., Fujiwara, H., Yamamoto, K., Kudo, Y., Nakagawa, H., Tanaka, Y., Ijichi, H., Ikenoue, T., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03381-1 · Cited by 30
Self-citationHepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
Tovo, C. V., de Mattos, Â. Z., Coral, G. P., SARTORI, G. D. P., Nogueira, L. V., Both, G. T., Villela‐Nogueira, C. A., & de Mattos, Â. A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i2.343 · Cited by 35
Expression and prognostic significance of miR-375 and miR-221 in liver cancer
Xie, D., Yuan, P., Wang, D., Jin, H., & Chen, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6423 · Cited by 28
Pathogenesis of NASH and Promising Natural Products
Leng, Y., Zhang, M., Luo, J., & Zhang, H. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60002-x · Cited by 29
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Chua, D., Low, Z. S., Cheam, G. X., Ng, A. S., & Tan, N. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314762 · Cited by 30
Yu, X. L., Deng, Q., Tang, Y., Xiao, L., Liu, L., Yao, P., Tang, H., & Dong, X. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03906 · Cited by 28
A complex auxiliary: IL-17/Th17 signaling during type 1 diabetes progression
Zheng, Z., & Zheng, F. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.11.007 · Cited by 27
Relieving ER stress to target NASH-driven hepatocellular carcinoma
Reibe, S., & Febbraio, M. A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0145-7 · Cited by 27
Strathearn, L. S., Stepanov, A. I., & Font-Burgada, J. (2020) · Nutrients · doi:10.3390/nu12040933 · Cited by 26
Self-citationAnticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats
Song, J., Ding, W., Liu, B., Liu, D., Xia, Z., Zhang, L., Cui, L., Luo, Y., Jia, X., & Feng, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11135 · Cited by 27
Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
Nagai, N., Kudo, Y., Aki, D., Nakagawa, H., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052238 · Cited by 30
Self-citationGenetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 27
Kohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
Allard, B., Jacoberger-Foissac, C., Cousineau, I., Barèche, Y., Buisseret, L., Chrobák, P., Allard, D., Pommey, S., Ah-Pine, F., Duquenne, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101188 · Cited by 27
Gong, L., Caetano, M. D. S., Cumpian, A. M., Daliri, S., Flores, A. G., Chang, S. H., Ochoa, C. E., Evans, C. M., Yu, Z., & Moghaddam, S. J. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1229724 · Cited by 27
Karin, M. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby005 · Cited by 27
Self-citationMao, Z., Ma, X., Jing, Y., Shen, M., Ma, X., Zhu, J., Liu, H., Zhang, G., & Chen, F. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06095-2 · Cited by 26
Wu, R., Nakatsu, G., Zhang, X., & Yu, J. Q. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1125883 · Cited by 26
Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer
Nakagawa, H., Hayata, Y., Yamada, T., Kawamura, S., Suzuki, N., & Koike, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061745 · Cited by 27
Self-citationFan, W., Bradford, T. M., & Török, N. J. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15184 · Cited by 25
Intracellular XBP1-IL-24 axis dismantles cytotoxic unfolded protein response in the liver
Wang, J., Hu, B., Zhao, Z., Zhang, H., Zhang, H., Zhao, Z., Ma, X., Shen, B., Sun, B., Huang, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2209-6 · Cited by 25
Ande, S. R., Nguyen, K. H., Padilla‐Meier, G. P., Nyomba, B. L. G., & Mishra, S. (2016) · Oncogene · doi:10.1038/onc.2015.501 · Cited by 29
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice
Shi, S. Y., Luk, C. T., Schroer, S. A., Kim, M. J., Dodington, D. W., Sivasubramaniyam, T., Lin, L. E., Cai, E. P., Lu, S.-Y., Wagner, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752519 · Cited by 23
Metabolic injury of hepatocytes promotes progression of NAFLD and AALD
Carvalho-Gontijo, R., Han, C., Zhang, L., Zhang, V., Hosseini, M., Mekeel, K., Schnabl, B., Loomba, R., Karin, M., Brenner, D. A., et al. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755316 · Cited by 23
Self-citationRibas, V., de la Rosa, L. C., Robles, D., Núñez, S., Segalés, P., Insausti-Urkia, N., Solsona‐Vilarrasa, E., Fernández-Checa, J. C., & García‐Ruiz, C. (2021) · Cancers · doi:10.3390/cancers13164091 · Cited by 26
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
Fang, J., Celton‐Morizur, S., & Desdouets, C. (2023) · Cancers · doi:10.3390/cancers15143723 · Cited by 25
Cellular stress and coagulation factor production: when more is not necessarily better
Chen, Z., Herzog, R. W., & Kaufman, R. J. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.10.005 · Cited by 24
Self-citationAdipose tissue-derived mediators of systemic inflammation and metabolic control
Alexaki, V. I. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100560 · Cited by 29
Leslie, J., Krishnamurthy, K. A., Gopalsamy, I. K., Inácio, P., Huch, M., Gallage, S., Oakley, F., & Vacca, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01162-9 · Cited by 27
Preclinical mouse models of hepatocellular carcinoma: An overview and update
Gu, C. Y., & Lee, T. K. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113042 · Cited by 24
Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis
Yamaguchi, T., Yoshida, K., Murata, M., Suwa, K., Tsuneyama, K., Matsuzaki, K., & Naganuma, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116270 · Cited by 25
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma
Ebrahimi, N., Far, N. P., Fakhr, S. S., Faghihkhorasani, F., Miraghel, S. A., Chaleshtori, S. R., Rezaei‐Tazangi, F., Beiranvand, S., Baziyar, P., Manavi, M. S., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115914 · Cited by 24
Xie, D., Yuan, P., Wang, D., Jin, H., & Chen, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6278 · Cited by 23
Li, M., Liu, S., Tan, L., Luo, Y., Gao, Z., Liu, J., Wu, Y., Fan, W., Saeger, S. D., & Song, S. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113263 · Cited by 22
Role of ER Stress in Xenobiotic‐Induced Liver Diseases and Hepatotoxicity
Zhang, Y., Qi, Y., Huang, S., Jiang, X., Xiao, W., Wang, L., Liu, Z., & Liu, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4640161 · Cited by 25
Gromowski, T., Lukacs‐Kornek, V., & Cisowski, J. (2023) · Cancer Cell International · doi:10.1186/s12935-022-02843-0 · Cited by 25
The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors
Khambu, B., Hong, H., Liu, S., Liu, G., Chen, X., Dong, Z., Wan, J., & Yin, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2536-7 · Cited by 22
Characterizing the Mechanism Behind the Progression of NAFLD to Hepatocellular Carcinoma
Nahon, P., Allaire, M., Nault, J., & Paradis, V. (2020) · Hepatic Oncology · doi:10.2217/hep-2020-0017 · Cited by 23
Okuda, K., Umemura, A., Umemura, S., Kataoka, S., Taketani, H., Seko, Y., Nishikawa, T., Yamaguchi, K., Moriguchi, M., Kanbara, Y., et al. (2021) · Cancers · doi:10.3390/cancers13071515 · Cited by 19
Self-citationShu, X., Wang, Q., & Wu, Q. (2022) · ONCOLOGIE · doi:10.32604/oncologie.2022.023248 · Cited by 21
Li, Z., Han, C., & Feng, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6681 · Cited by 20
Flaherty, D. P., Miller, J. R., Garshott, D. M., Hedrick, M., Gosalia, P., Li, Y., Milewski, M., Sugarman, E. D., Vasile, S., Salaniwal, S., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5003234 · Cited by 21
Self-citationKuo, J., Serrano, S. S., Grönberg, A., Massoumi, R., Hansson, M. J., & Gallay, P. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01129 · Cited by 20
Sasaki, R., Kanda, T., Nakamura, M., Nakamoto, S., Haga, Y., Wu, S., Shirasawa, H., & Yokosuka, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146314 · Cited by 20
The essential functions of endoplasmic reticulum chaperones in hepatic lipid metabolism
Zhang, L., & Wang, H. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.03.016 · Cited by 21
Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease
Xu, Y., An, Z., Wang, S., Ni, Y., Zhou, M., Feng, Q., Gou, X., Xu, M., & Qi, Y. (2023) · Current Molecular Pharmacology · doi:10.2174/0118761429259143230927110556 · Cited by 19
Kakehashi, A., Suzuki, S., & Wanibuchi, H. (2023) · Cancers · doi:10.3390/cancers15184566 · Cited by 19
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma
Elaimy, A. L., El-Derany, M. O., James, J. G., Wang, Z., Pearson, A. N., Holcomb, E. A., Huber, A. K., Gijón, M. A., Bell, H. N., Sanghvi, V. R., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.184826 · Cited by 19
Xiao, M., Chen, W., Wang, C., Wu, Y., Zhu, S., Zeng, C., Cai, Y., Liu, C., & He, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23622 · Cited by 21
Okuno, T., Kakehashi, A., Ishii, N., Fujioka, M., Min, G., & Wanibuchi, H. (2018) · Cancers · doi:10.3390/cancers10120465 · Cited by 19
Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
He, J., Li, G., Liu, X., Ma, L., Zhang, P., Zhang, J., Zheng, S., Wang, J., & Liu, J. (2020) · BioMed Research International · doi:10.1155/2020/1936385 · Cited by 18
Kurhe, Y., Caputo, M., Cansby, E., Xia, Y., Kumari, S., Anand, S. K., Howell, B. W., Marschall, H., & Mahlapuu, M. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.018 · Cited by 20
Endoplasmic reticulum stress at the forefront of fatty liver diseases and cancer
Karin, M., & Kim, J. Y. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100096 · Cited by 20
Self-citationAlbadawy, R. M., Agwa, S. H. A., Khairy, E., Saad, M., Touchy, N. E., Othman, M. O., El‐Kassas, M., & Matboli, M. (2021) · Genes · doi:10.3390/genes12111813 · Cited by 18
Vesting, A. J., Jais, A., Klemm, P., Steuernagel, L., Wienand, P., Fog-Tonnesen, M., Hvid, H., Schumacher, A.-L., Kukat, C., Nolte, H., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101626 · Cited by 17
Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy
Chen, S., Duan, H., & Sun, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114963 · Cited by 18
Lipogenesis and MASLD: re-thinking the role of SREBPs
Nakagawa, H. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04052-w · Cited by 19
Self-citationBluemel, S., Wang, Y., Lee, S., & Schnabl, B. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i33.4933 · Cited by 17
Obesity and cancer: Mouse models used in studies
Zhang, B., Xu, J., Wang, W., Zeng, Y., & Jiang, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1125178 · Cited by 17
Unveiling the cancer risk nexus of the steatotic liver
Kim, J., & Seki, E. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.017 · Cited by 17
Self-citationHe, Y., Li, D., & Gao, G. (2024) · Molecules · doi:10.3390/molecules29112630 · Cited by 17
ER stress and hexosamine pathway during tumourigenesis: A pas de deux?
Vasseur, S., & Manié, S. N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.001 · Cited by 18
Chen, X., Liu, C., & Ruan, L. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06280-9 · Cited by 17
Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver
Hu, M., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805760 · Cited by 17
Metadata
- Authors
- Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., Koike, K., Kaufman, R. J., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Kyushu University (JP)
- Universitat Autònoma de Barcelona (ES)
- The University of Tokyo (JP)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Karin, Michael
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 26
- Issue
- 3
- Pages
- 331-343
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4165611
- OpenAlex
- W2085390667
- Cited by
- 525
- References
- 38
- Citations by year
- 2026: 22 · 2025: 38 · 2024: 43 · 2023: 58 · 2022: 57 · 2021: 57 · 2020: 56 · 2019: 40 · 2018: 42 · 2017: 34 · 2016: 39 · 2015: 28 · 2014: 11
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Society for the Promotion of Science (24390183)
- National Heart, Lung, and Blood Institute (R01HL052173, HL052173-16)
- National Cancer Institute (R01CA118165, CA155120-02, R01CA155120, P30CA023100, CA118165-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088227, DK042394-18, DK088227-06)
- National Institute of Environmental Health Sciences (P42ES010337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- endoplasmic reticulum stress, overnutrition, hepatocellular carcinoma, nonalcoholic steatohepatitis, TNF-α, plasminogen activator, high-fat diet, insulin resistance, hepatic steatosis, inflammatory macrophages, lipogenesis
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Animals, Cells, Cultured, Fatty Liver, Heat-Shock Proteins, Carcinoma, Hepatocellular, Liver Neoplasms, Experimental, Male, Mice, Transgenic, Tumor Necrosis Factor-alpha, Urokinase-Type Plasminogen Activator, Signal Transduction, Overnutrition, Tumor Burden, Receptors, Tumor Necrosis Factor, Type I, Lipogenesis, Mice, Diet, High-Fat, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
